Using Red Light to Improve Metabolism & the Harmful Effects of LEDs | Dr. Glen Jeffery

Episode Summary

Executive Summary: Neuroscientist Glenn Jeffrey argues that light affects health partly through mitochondrial function, with long wavelengths potentially supporting cellular energy and short-wavelength-rich LED lighting potentially disrupting it. He describes studies of vision, glucose responses, and animal health, while stressing that benefits may depend on timing and early intervention. The discussion advocates more daylight and better-balanced indoor lighting, but many proposed health implications remain under investigation.

Main Topics: Light spectrum, absorption, and mitochondria: The speakers distinguish visible light from ultraviolet and infrared wavelengths. Jeffrey proposes that long-wavelength light may influence mitochondrial activity through water surrounding the mitochondria, potentially supporting ATP production and mitochondrial proteins; he presents this as an evolving hypothesis rather than a fully settled mechanism. Long-wavelength light and metabolic or systemic effects: Jeffrey describes experiments in which red or long-wavelength exposure was associated with a smaller blood-glucose rise after a glucose challenge. He also discusses animal research suggesting effects beyond the illuminated area, possibly involving communication between mitochondria and other tissues. Vision, aging, and eye disease: The conversation covers studies reporting improved color-vision thresholds after brief 670-nanometer exposure, with effects lasting several days. Jeffrey says outcomes vary by age and disease stage, and argues that intervention is more promising before retinal or other disease is advanced. Artificial lighting and potential LED concerns: Jeffrey raises concern that common LEDs can be enriched in short wavelengths around 420–440 nanometers while providing little infrared, unlike sunlight, firelight, or incandescent lighting. Animal findings discussed include changes in mitochondrial function, glucose control, weight, liver, and reproductive measures; the speakers frame possible human public-health consequences as a concern needing further study. Daylight, UV exposure, and health trade-offs: The speakers support daylight exposure while avoiding sunburn and discuss research associating more sunlight with lower all-cause mortality. They note that these associations and the risks and benefits of UV exposure require careful interpretation, rather than treating sunlight as uniformly harmful or beneficial. Practical lighting and built environments: Suggestions include spending time outdoors, improving access to daylight in schools and care settings, and considering halogen or incandescent lamps as sources of broader-spectrum light. Jeffrey also discusses windows that block infrared and plants reflecting infrared, while acknowledging that optimal lighting standards and effective interventions remain open questions.

Key Arguments: Jeffrey argues that long-wavelength light may support mitochondrial function, potentially by affecting water in the mitochondria's environment and, over time, mitochondrial protein production. He emphasizes that the precise mechanism is not fully established. In a human glucose-tolerance experiment described in the episode, exposure to red light before the test was associated with a blood-glucose peak roughly 20% lower than without that exposure. The light was applied to a small area of the back, and the speakers interpret the systemic result as evidence that effects may extend beyond the illuminated tissue. Jeffrey reports that brief 670-nanometer exposure improved color-vision thresholds in most tested participants; the effect was reported to last about five days. He says responses varied and were generally stronger when mitochondrial function was more impaired. The guest describes animal findings under LED lighting, including poorer mitochondrial measures and metabolic or organ changes, and argues that the imbalance between short and long wavelengths—not simply the presence of one color—is a central concern. These animal findings do not by themselves establish equivalent harms in people. The speakers favor regular daylight exposure without sunburn. They cite observational associations between sunlight and lower all-cause mortality, while acknowledging that the relationship between sunlight, UV, and particular cancers remains complex and unsettled. Jeffrey argues that light interventions are more likely to help early than after disease has become severe, citing mixed results in macular degeneration and other conditions, alongside promising individual cases and ongoing clinical research. The discussion recommends considering the whole lighting environment—including daylight access, spectral balance, timing, and windows—rather than focusing only on screens or buying a specific red-light device. The speakers caution against using lasers outside appropriate medical contexts.

Data Points: Approximate visible-light wavelength range: 400–700 nanometers - Jeffrey gives this as the approximate range people can see. Approximate sunlight wavelength range discussed: About 300 to nearly 3,000 nanometers - The lower end extends into ultraviolet and the upper range into infrared; the figures are presented as approximate. Wavelength used in vision experiments: 670 nanometers - Jeffrey says this deep-red wavelength was used in early human studies. Exposure duration and reported vision effect: 3 minutes; effect reported for about 5 days - The episode describes brief exposure followed by improved color-vision thresholds, with the effect lasting several days. Reported reduction in glucose response: Just over 20% - Jeffrey describes a smaller glucose peak after red-light exposure before a glucose-tolerance test; this is a reported study result, not a general treatment recommendation. Area illuminated in the glucose experiment: Approximately 4 by 6 inches - The speakers estimate the small patch of skin illuminated on participants' backs. Light intensity used in later lab experiments: About 8 milliwatts per square centimeter; an observed effect near 1 milliwatt per square centimeter - Jeffrey contrasts this with earlier experiments using about 40 milliwatts per square centimeter and says lower intensities also appeared effective in their work. LED short-wavelength range of concern: About 420–440 nanometers - Jeffrey identifies this range as one of concern in his discussion of LED lighting and mitochondrial effects. Rod photoreceptor loss with age: About one-third over a lifetime - Jeffrey cites this as a general estimate while explaining experiments in which red-light exposure reduced rod-cell loss in aging mice. Macular degeneration estimate: About 20% by age 100 - Jeffrey gives this as a conditional estimate if a population lived to 100; it is not presented as a study result from the episode.

Pivotal Quotes: "This is an issue on the same level as asbestos. This is a public health issue and it's big." — Glenn Jeffrey: Jeffrey's forceful characterization of his concern about modern indoor lighting; the transcript presents this as his view, not a settled conclusion. "The real big point to take on board is it's a switch. There's not a dose response curve here. It is a switch." — Glenn Jeffrey: His description of the threshold-like response reported in some light-exposure experiments. "I think you've got it in one there. As opposed to being quote-unquote toxic, right? It would be like saying, we need all three macronutrients." — Glenn Jeffrey: Jeffrey agrees with Huberman's framing that the balance of wavelengths may matter more than labeling short-wavelength light inherently harmful.

Implications: Listeners can prioritize outdoor daylight, avoid sunburn, and consider how much time they spend under indoor lighting. The research discussed is promising but incomplete: animal and small-study findings do not establish broad clinical benefits or prove LED harms in humans, so lighting changes should not replace medical care.